Trials / Completed
CompletedNCT01940445
Impact of Synergistic Sequential Treatment (SST)
Impact of Synergistic Sequential Treatment (SST) of Fractional Non-ablative and Q-Switched Lasers on Skin Texture
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Lumenis Be Ltd. · Industry
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
At least thirty (30) subjects, Fitzpatrick-Goldman Skin Type II-V will be enrolled in 2 clinical sites; each clinic will enroll at least 15 subjects. Subjects should present visible wrinkles and/or elastosis requiring treatment. Hypothesis: The SST will improve the appearance of the wrinkles/elastosis as well as general skin tone by at least 25% as compared to M22 ResurFX 1565nm module alone, for at least 75% of the subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | M22 ResurFX | Fractional NA treatment (ResurFX) on one side of the face |
| DEVICE | M22 ResurFX and QS | Fractional NA treatment followed by QS laser treatment (SST) on one side of the face |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2013-09-12
- Last updated
- 2017-01-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01940445. Inclusion in this directory is not an endorsement.